CN Patent

CN107278154B — 用于治疗低血糖的鼻粉末制剂

Assigned to Eli Lilly and Co · Expires 2021-04-09 · 5y expired

What this patent protects

本发明提供了用于鼻施用的含有胰高血糖素或胰高血糖素类似物的粉末制剂，其可用于治疗低血糖，且特别是治疗严重低血糖。本发明还提供了制备该粉末制剂的方法，和用于使用所述粉末制剂的设备和方法。

USPTO Abstract

本发明提供了用于鼻施用的含有胰高血糖素或胰高血糖素类似物的粉末制剂，其可用于治疗低血糖，且特别是治疗严重低血糖。本发明还提供了制备该粉末制剂的方法，和用于使用所述粉末制剂的设备和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN107278154B
Jurisdiction
CN
Classification
—
Expires
2021-04-09
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.